Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CRISPR Therapeutics AG CRSP

Full chart Compare
Set alert

Price alert · CRSP

All alert types
50.07 USD +1.51 (+3.11%)

At closeNov 6, 2026, 7:40 PM EST

49.35 -0.72 -1.44%

After hours · Nov 6, 7:40 PM ET

48.41 Day range 50.27
44.34 52-week range 61.89
YTD
-4.52%
1 year
-11.55%

Financial health

Altman Z-Score

2.36 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -8.1×
FY 2016: -10.7×FY 2017: -13.7×FY 2018: -8.3×FY 2019: 49.5×FY 2020: -28.9×FY 2021: 15.2×FY 2022: -4.9×FY 2023: -32.3×FY 2024: -9.1×FY 2025: -8.1×
FY 2016 5y median -8.1× FY 2025
P/S 1343×
FY 2016: 48.1×FY 2017: 22.9×FY 2018: 439×FY 2019: 11.4×FY 2020: 14044×FY 2021: 6.3×FY 2022: 7249×FY 2023: 13.4×FY 2024: 94.9×FY 2025: 1343×
FY 2016 5y median 94.9× FY 2025
P/B 2.5×
FY 2016: 1.1×FY 2017: 5.0×FY 2018: 3.5×FY 2019: 3.5×FY 2020: 6.1×FY 2021: 2.4×FY 2022: 1.7×FY 2023: 2.6×FY 2024: 1.7×FY 2025: 2.5×
FY 2016 5y median 2.4× FY 2025
P/FCF -13.6×
FY 2016: -4.3×FY 2017: -12.0×FY 2018: -13.8×FY 2019: 66.3×FY 2020: -39.3×FY 2021: 12.6×FY 2022: -5.9×FY 2023: -18.4×FY 2024: -23.0×FY 2025: -13.6×
FY 2016 5y median -13.6× FY 2025
EV/EBITDA -8.5×
FY 2016: 4.9×FY 2017: -11.3×FY 2018: -5.9×FY 2019: 47.1×FY 2020: -26.0×FY 2021: 12.7×FY 2022: -5.1×FY 2023: -36.7×FY 2024: -9.5×FY 2025: -8.5×
FY 2016 5y median -8.5× FY 2025
EV/Sales 1355×
FY 2016: -13.0×FY 2017: 17.0×FY 2018: 292×FY 2019: 8.4×FY 2020: 12504×FY 2021: 5.5×FY 2022: 7322×FY 2023: 13.0×FY 2024: 92.7×FY 2025: 1355×
FY 2016 5y median 92.7× FY 2025
FCF Yield -7.3%
FY 2016: -23.5%FY 2017: -8.3%FY 2018: -7.2%FY 2019: 1.5%FY 2020: -2.5%FY 2021: 7.9%FY 2022: -16.9%FY 2023: -5.4%FY 2024: -4.4%FY 2025: -7.3%
FY 2016 5y median -5.4% FY 2025

Profitability

Gross Margin -6537.0%
FY 2016: -717.9%FY 2017: -70.3%FY 2018: -3541.9%FY 2019: 38.1%FY 2020: -37369.7%FY 2021: 88.9%FY 2022: -25186.7%FY 2023: 64.8%FY 2024: -215.0%FY 2025: -6537.0%
FY 2016 5y median -215.0% FY 2025
Operating Margin -16191.4%
FY 2016: -1319.3%FY 2017: -157.7%FY 2018: -5087.8%FY 2019: 16.1%FY 2020: -49295.5%FY 2021: 40.9%FY 2022: -154394.7%FY 2023: -60.1%FY 2024: -1333.0%FY 2025: -16191.4%
FY 2016 5y median -1333.0% FY 2025
Net Margin -16569.8%
FY 2016: -449.3%FY 2017: -166.7%FY 2018: -5281.1%FY 2019: 23.1%FY 2020: -48520.9%FY 2021: 41.4%FY 2022: -149122.7%FY 2023: -41.5%FY 2024: -1046.4%FY 2025: -16569.8%
FY 2016 5y median -1046.4% FY 2025
ROE -30.3%
FY 2016: -10.0%FY 2017: -36.4%FY 2018: -42.1%FY 2019: 7.1%FY 2020: -21.0%FY 2021: 15.7%FY 2022: -34.7%FY 2023: -8.2%FY 2024: -19.0%FY 2025: -30.3%
FY 2016 5y median -19.0% FY 2025
ROIC -26.6%
FY 2016: -21.1%FY 2017: -25.2%FY 2018: -34.5%FY 2019: 4.6%FY 2020: -20.3%FY 2021: 14.1%FY 2022: -31.5%FY 2023: -10.4%FY 2024: -21.5%FY 2025: -26.6%
FY 2016 5y median -21.5% FY 2025
ROA -25.7%
FY 2016: -6.7%FY 2017: -25.2%FY 2018: -33.7%FY 2019: 6.3%FY 2020: -19.1%FY 2021: 13.7%FY 2022: -29.0%FY 2023: -6.9%FY 2024: -16.3%FY 2025: -25.7%
FY 2016 5y median -16.3% FY 2025

Growth (YoY)

Revenue -90.0%
FY 2016: 1990.7%FY 2017: 693.9%FY 2018: -92.4%FY 2019: 9169.8%FY 2020: -99.8%FY 2021: 126893.2%FY 2022: -100.0%FY 2023: 84762.4%FY 2024: -90.5%FY 2025: -90.0%
FY 2016 FY 2025
Operating Income -21.8%
FY 2016: -164.8%FY 2017: 5.1%FY 2018: -145.9%FY 2019: 129.4%FY 2020: -858.3%FY 2021: 205.4%FY 2022: -280.2%FY 2023: 66.9%FY 2024: -109.7%FY 2025: -21.8%
FY 2016 FY 2025
EPS (diluted) -49.1%
FY 2016: -114.8%FY 2017: 9.5%FY 2018: -101.2%FY 2019: 134.0%FY 2020: -552.1%FY 2021: 188.8%FY 2022: -277.9%FY 2023: 76.8%FY 2024: -123.7%FY 2025: -49.1%
FY 2016 FY 2025
Free Cash Flow -139.1%
FY 2016: -200.1%FY 2017: -33.6%FY 2018: -27.1%FY 2019: 150.5%FY 2020: -613.5%FY 2021: 278.1%FY 2022: -216.5%FY 2023: 49.4%FY 2024: 46.4%FY 2025: -139.1%
FY 2016 FY 2025

Financial Health

Current Ratio 13.3×
FY 2016: 14.6×FY 2017: 17.1×FY 2018: 16.8×FY 2019: 17.3×FY 2020: 18.2×FY 2021: 20.2×FY 2022: 15.3×FY 2023: 17.5×FY 2024: 22.1×FY 2025: 13.3×
FY 2016 5y median 17.5× FY 2025
Quick Ratio 13.3×
FY 2016: 14.6×FY 2017: 17.1×FY 2018: 16.8×FY 2019: 17.3×FY 2020: 18.2×FY 2021: 20.2×FY 2022: 15.3×FY 2023: 17.5×FY 2024: 22.1×FY 2025: 13.3×
FY 2016 5y median 17.5× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: 23.0×FY 2017: 3.9×FY 2018: 2.9×FY 2019: -17.3×FY 2020: 3.2×FY 2021: -1.8×FY 2022: -0.1×FY 2023: 1.2×FY 2024: 0.2×FY 2025: -0.1×
FY 2016 5y median -0.1× FY 2025
Interest Coverage 0.0×
FY 2016: -8.5×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31